Skip to main content
Senate Bill 0503

Senate Bill 0503

ARCHIVE (2011)

Latest Information

DIGEST OF SB 503 (Updated April 29, 2011 11:14 am - DI 106)

Sale of ephedrine or pseudoephedrine. Defines "retailer" and provides that the duties relating to the electronic tracking of ephedrine and pseudoephedrine (PSE) apply only to retailers. Requires a retailer to submit information relating to the purchase of nonprescription PSE to the National Precursor Log Exchange (NPLEx) administered by the National Association of Drug Diversion Investigators (NADDI) before completing a sale, and prohibits a retailer from completing a sale if NPLEx generates a "stop sale" notice. Provides that the maximum amount of PSE that may be purchased by an individual in a 30 day period is 7.2 grams. Requires PSE containing substances to be kept behind the counter, and specifies that the PSE weight limits apply to the base amount of PSE in the drug. Provides that a retailer who uses the electronic sales tracking system is liable for any negligent, reckless, deliberate, or wanton act or omission committed in carrying out the duties required by this section, and provides that a retailer may be liable to a third party for a violation of the duties required in using the electronic sales tracking system. Specifies that: (1) a law enforcement official may access Indiana transaction information contained in the NPLEx; (2) information contained in the NPLEx may be shared only with law enforcement officials; (3) NADDI may not modify information shared with law enforcement officials; and (4) NADDI shall forward Indiana data contained in the NPLEx at least one time per week to the state police department.
    Current Status:
    Law Enacted
    Latest Printing (PDF)